» Articles » PMID: 38479983

In-depth Multiomic Characterization of the Effects of Obesity in High-fat Diet-fed Mice

Overview
Journal FEBS Open Bio
Specialty Biology
Date 2024 Mar 13
PMID 38479983
Authors
Affiliations
Soon will be listed here.
Abstract

High-fat diet (HFD)-fed mice have been widely used in the clinical investigation of obesity. However, the long-term effect of HFD on gut microbiota and metabolites, plasma and liver metabolomics, colonic and liver transcriptomics remain largely unknown. In this study, 6-week-old C57BL/6J male mice fed with HFD for 14 weeks showed increased obesity-related indexes including alanine aminotransferase, aspartate aminotransferase, total cholesterol, total triglyceride, free fatty acids, lipopolysaccharides, IL-6, and TNFα. Furthermore, microbial diversity and richness were also significantly decreased. In the colon, genes involved in tryptophan metabolism, PPAR signaling pathway, cholesterol metabolism, and lipid localization and transport, were upregulated. While in the liver, MAPK signaling and unsaturated fatty acid biosynthesis were upregulated. Metabolomic analyses revealed decreased levels of glycerophospholipids and fatty acyl, but increased amino acids, coenzymes and vitamins, and organic acids in the colon, suggesting high absorption of oxidized lipids, while acyl-carnitine, lysophosphatidylcholine, lysophosphatidylethanolamine, and oxidized lipids were reduced in the liver, suggesting a more active lipid metabolism. Finally, correlation analyses revealed a positive correlation between gut microbiota and metabolites and the expression of genes associated with lipid localization, absorption, and transport in the colon, and nutrients and energy metabolism in the liver. Taken together, our results provide a comprehensive characterization of long-term HFD-induced obesity in mice.

Citing Articles

Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT receptor antagonist telmisartan.

Freschi M, Kunstner A, Huber G, Stolting I, Busch H, Hirose M Front Pharmacol. 2024; 15:1453989.

PMID: 39624839 PMC: 11608989. DOI: 10.3389/fphar.2024.1453989.

References
1.
Gomes A, Hoffmann C, Mota J . The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018; 9(4):308-325. PMC: 6219651. DOI: 10.1080/19490976.2018.1465157. View

2.
. CORRIGENDUM. Am J Physiol Endocrinol Metab. 2023; 319(2):E458. PMC: 10409521. DOI: 10.1152/ajpendo.zh1-8421-corr.2020. View

3.
Zhang Y, Guo S, Xie C, Fang J . Uridine Metabolism and Its Role in Glucose, Lipid, and Amino Acid Homeostasis. Biomed Res Int. 2020; 2020:7091718. PMC: 7180397. DOI: 10.1155/2020/7091718. View

4.
Tripathi A, Debelius J, Brenner D, Karin M, Loomba R, Schnabl B . The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018; 15(7):397-411. PMC: 6319369. DOI: 10.1038/s41575-018-0011-z. View

5.
Wang B, Kong Q, Li X, Zhao J, Zhang H, Chen W . A High-Fat Diet Increases Gut Microbiota Biodiversity and Energy Expenditure Due to Nutrient Difference. Nutrients. 2020; 12(10). PMC: 7589760. DOI: 10.3390/nu12103197. View